InvestorsHub Logo

H2R

Followers 42
Posts 2159
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: None

Wednesday, 04/11/2018 3:06:36 PM

Wednesday, April 11, 2018 3:06:36 PM

Post# of 4817
SoS on ATRS from a couple days ago:

https://smithonstocks.com/antares-pharma-approval-of-xyosted-on-or-before-september-29-2018-is-highly-probable-atrs-buy-2-12/

Interesting take on the speed of the FDA acting on the Xyosted (re)-submission and the role and incentives of PBMs.

And a really well informed comment posted to that article about the different potential value creators at ATRS (EpiPen, Forteo).